Literature DB >> 24362934

Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis.

Noriko Komatsu1, Kazuo Okamoto1, Shinichiro Sawa1, Tomoki Nakashima2, Masatsugu Oh-hora3, Tatsuhiko Kodama4, Sakae Tanaka5, Jeffrey A Bluestone6, Hiroshi Takayanagi7.   

Abstract

Autoimmune diseases often result from an imbalance between regulatory T (Treg) cells and interleukin-17 (IL-17)-producing T helper (TH17) cells; the origin of the latter cells remains largely unknown. Foxp3 is indispensable for the suppressive function of Treg cells, but the stability of Foxp3 has been under debate. Here we show that TH17 cells originating from Foxp3(+) T cells have a key role in the pathogenesis of autoimmune arthritis. Under arthritic conditions, CD25(lo)Foxp3(+)CD4(+) T cells lose Foxp3 expression (herein called exFoxp3 cells) and undergo transdifferentiation into TH17 cells. Fate mapping analysis showed that IL-17-expressing exFoxp3 T (exFoxp3 TH17) cells accumulated in inflamed joints. The conversion of Foxp3(+)CD4(+) T cells to TH17 cells was mediated by synovial fibroblast-derived IL-6. These exFoxp3 TH17 cells were more potent osteoclastogenic T cells than were naive CD4(+) T cell-derived TH17 cells. Notably, exFoxp3 TH17 cells were characterized by the expression of Sox4, chemokine (C-C motif) receptor 6 (CCR6), chemokine (C-C motif) ligand 20 (CCL20), IL-23 receptor (IL-23R) and receptor activator of NF-κB ligand (RANKL, also called TNFSF11). Adoptive transfer of autoreactive, antigen-experienced CD25(lo)Foxp3(+)CD4(+) T cells into mice followed by secondary immunization with collagen accelerated the onset and increased the severity of arthritis and was associated with the loss of Foxp3 expression in the majority of transferred T cells. We observed IL-17(+)Foxp3(+) T cells in the synovium of subjects with active rheumatoid arthritis (RA), which suggests that plastic Foxp3(+) T cells contribute to the pathogenesis of RA. These findings establish the pathological importance of Foxp3 instability in the generation of pathogenic TH17 cells in autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24362934     DOI: 10.1038/nm.3432

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  42 in total

1.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5.

Authors:  Xiang-Ping Yang; Kamran Ghoreschi; Scott M Steward-Tharp; Jaime Rodriguez-Canales; Jinfang Zhu; John R Grainger; Kiyoshi Hirahara; Hong-Wei Sun; Lai Wei; Golnaz Vahedi; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

2.  Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity.

Authors:  Noriko Komatsu; Maria Encarnita Mariotti-Ferrandiz; Ying Wang; Bernard Malissen; Herman Waldmann; Shohei Hori
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

3.  T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development.

Authors:  Naganari Ohkura; Masahide Hamaguchi; Hiromasa Morikawa; Kyoko Sugimura; Atsushi Tanaka; Yoshinaga Ito; Motonao Osaki; Yoshiaki Tanaka; Riu Yamashita; Naoko Nakano; Jochen Huehn; Hans Joerg Fehling; Tim Sparwasser; Kenta Nakai; Shimon Sakaguchi
Journal:  Immunity       Date:  2012-11-01       Impact factor: 31.745

4.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia.

Authors:  Parham Ramezani-Rad; Huimin Geng; Christian Hurtz; Lai N Chan; Zhengshan Chen; Hassan Jumaa; Ari Melnick; Elisabeth Paietta; William L Carroll; Cheryl L Willman; Véronique Lefebvre; Markus Müschen
Journal:  Blood       Date:  2012-11-14       Impact factor: 22.113

Review 7.  T cells out of control--impaired immune regulation in the inflamed joint.

Authors:  Ellen J Wehrens; Berent J Prakken; Femke van Wijk
Journal:  Nat Rev Rheumatol       Date:  2013-01       Impact factor: 20.543

8.  Treg cells suppress osteoclast formation: a new link between the immune system and bone.

Authors:  Mario M Zaiss; Roland Axmann; Jochen Zwerina; Karin Polzer; Eva Gückel; Alla Skapenko; Hendrik Schulze-Koops; Nikki Horwood; Andrew Cope; Georg Schett
Journal:  Arthritis Rheum       Date:  2007-12

9.  Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells.

Authors:  Takahisa Miyao; Stefan Floess; Ruka Setoguchi; Hervé Luche; Hans Joerg Fehling; Herman Waldmann; Jochen Huehn; Shohei Hori
Journal:  Immunity       Date:  2012-02-09       Impact factor: 31.745

10.  Local microbleeding facilitates IL-6- and IL-17-dependent arthritis in the absence of tissue antigen recognition by activated T cells.

Authors:  Masaaki Murakami; Yuko Okuyama; Hideki Ogura; Shogo Asano; Yasunobu Arima; Mineko Tsuruoka; Masaya Harada; Minoru Kanamoto; Yukihisa Sawa; Yoichiro Iwakura; Kiyoshi Takatsu; Daisuke Kamimura; Toshio Hirano
Journal:  J Exp Med       Date:  2011-01-10       Impact factor: 14.307

View more
  417 in total

1.  Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity.

Authors:  Jellert T Gaublomme; Nir Yosef; Youjin Lee; Rona S Gertner; Li V Yang; Chuan Wu; Pier Paolo Pandolfi; Tak Mak; Rahul Satija; Alex K Shalek; Vijay K Kuchroo; Hongkun Park; Aviv Regev
Journal:  Cell       Date:  2015-11-19       Impact factor: 41.582

Review 2.  Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

Authors:  Michel DuPage; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2016-02-15       Impact factor: 53.106

3.  Schistosoma japonicum cystatin attenuates murine collagen-induced arthritis.

Authors:  Fang Liu; Weisheng Cheng; Faustina Pappoe; Xiaodong Hu; Huiqin Wen; Qingli Luo; Shushu Wang; Fang Deng; Yuanyuan Xie; Yuanhong Xu; Jilong Shen
Journal:  Parasitol Res       Date:  2016-07-08       Impact factor: 2.289

4.  TGF-β-induced CD4+Foxp3+ T cells attenuate acute graft-versus-host disease by suppressing expansion and killing of effector CD8+ cells.

Authors:  Jian Gu; Ling Lu; Maogen Chen; Lili Xu; Qin Lan; Qiang Li; Zhongmin Liu; Guihua Chen; Ping Wang; Xuehao Wang; David Brand; Nancy Olsen; Song Guo Zheng
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

Review 5.  Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.

Authors:  Grant C Hughes; Divaker Choubey
Journal:  Nat Rev Rheumatol       Date:  2014-08-26       Impact factor: 20.543

6.  Two histone/protein acetyltransferases, CBP and p300, are indispensable for Foxp3+ T-regulatory cell development and function.

Authors:  Yujie Liu; Liqing Wang; Rongxiang Han; Ulf H Beier; Tatiana Akimova; Tricia Bhatti; Haiyan Xiao; Philip A Cole; Paul K Brindle; Wayne W Hancock
Journal:  Mol Cell Biol       Date:  2014-08-25       Impact factor: 4.272

7.  CD4+CD126low/- Foxp3+ Cell Population Represents a Superior Subset of Regulatory T Cells in Treating Autoimmune Diseases.

Authors:  Ye Chen; Zhenjian Xu; Rongzhen Liang; Julie Wang; Anping Xu; Ning Na; Bin Li; Ruoning Wang; Miller Joseph; Nancy Olsen; Willa Hsueh; Song Guo Zheng
Journal:  Mol Ther       Date:  2020-07-21       Impact factor: 11.454

Review 8.  Ubiquitous points of control over regulatory T cells.

Authors:  Fan Pan; Joseph Barbi
Journal:  J Mol Med (Berl)       Date:  2014-04-29       Impact factor: 4.599

9.  Pulsed low-dose RANKL as a potential therapeutic for postmenopausal osteoporosis.

Authors:  Anna Cline-Smith; Jesse Gibbs; Elena Shashkova; Zachary S Buchwald; Deborah V Novack; Rajeev Aurora
Journal:  JCI Insight       Date:  2016-08-18

Review 10.  Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.

Authors:  Prabhakaran Kumar; Shikha Saini; Saad Khan; Swarali Surendra Lele; Bellur S Prabhakar
Journal:  Cell Immunol       Date:  2018-09-29       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.